News

Myomo Resumes Fitting MyoPro Patients and Deliveries as States Begin to Re-Open after COVID-19 Shutdowns

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced it has resumed in-person patient visits for casting, fitting and delivering its MyoPro® powered braces in states that are now allowing such interactions. Read more >>
Read more...

Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that the last subject completed their final visit in the Company’s Phase 2b JBT101-CF-002 trial of lenabasum for the treatment of cystic fibrosis. Read more >>
Read more...

WFS GXS Conference

The flagship WFS Tech Conference for CEOs, founders, and investors of software and IT companies, covering Tech M&A: investment, growth, strategy, buyouts, sales, and mergers. Insights from: private equity, VC, angels, strategic buyers, M&A advisors, and CEOs who've had a successful exit. Ziad Moukheiber, President and CEO of Boston Harbor Angels, is one of the speakers. Read more >>
Read more...

Sustained Acoustic Medicine Device sam® Offers an Alternative Solution to Pain Medication and Surgery

The advanced sustained acoustic medicine device (sam®) from ZetrOZ Systems offers physicians and orthopedic surgeons an alternative solution to pain medication and surgery for their patients. Medical providers can prescribe sam®, the only FDA-cleared long-duration ultrasound device, for prescription home-use to treat arthritis and soft tissue injuries. Read more >>
Read more...